TrovaGene
Country
USA
Краткое название
TrovaGene
Headquarters
11055 Flintkote Avenue Suite B
Members of the board
Antonius Schuh, PhD,
Chief Executive Officer
Stephen Zaniboni, MBA, CPA,
Chief Financial Officer
Charlie Rodi, PhD,
VP & Chief Technology Officer
B. Keith McCormick, MBA,
VP, Commercial Operations
Michael Terry,
Vice President, Corporate Development
Mark Erlander, PhD,
Chief Scientific Officer
Categories medicine
Oncology, Infectious diseases, Urology
Stage of the project
Production
Disease
Cystitis, Influenza, Intestine cancer, Gastric cancer
Ticker
TROV
Current owners
Thomas Adams, PhD,
Chairman of the Board
John P. Brancaccio, CPA,
Director
Gabriele Cerrone, MBA,
Director
Gary Jacob, PhD,
Director
Chris McGuigan, PhD,
Director
Antonius Schuh, PhD,
Chief Executive Officer
Stanley Tennant, MD,
Director
Assets
252.6200
Technology
Bioengineering, Cell Technologies, Devices, Services, Chemistry